Equities research analysts expect CryoPort Inc. (NASDAQ:CYRX) to post earnings of ($0.07) per share for the current quarter, Zacks reports. Three analysts have made estimates for CryoPort’s earnings, with the highest EPS estimate coming in at ($0.07) and the lowest estimate coming in at ($0.08). CryoPort reported earnings of ($0.08) per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 12.5%. The business is expected to announce its next earnings results on Tuesday, August 14th.
According to Zacks, analysts expect that CryoPort will report full-year earnings of ($0.29) per share for the current financial year, with EPS estimates ranging from ($0.31) to ($0.27). For the next financial year, analysts forecast that the firm will report earnings of $0.01 per share, with EPS estimates ranging from ($0.13) to $0.24. Zacks’ earnings per share calculations are an average based on a survey of analysts that follow CryoPort.
CryoPort (NASDAQ:CYRX) last announced its quarterly earnings results on Thursday, May 3rd. The consumer goods maker reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.03). CryoPort had a negative net margin of 66.29% and a negative return on equity of 48.12%. The firm had revenue of $4.02 million during the quarter, compared to analysts’ expectations of $3.84 million. During the same quarter in the prior year, the business earned ($0.10) EPS. The company’s quarterly revenue was up 48.3% compared to the same quarter last year.
A number of research firms recently commented on CYRX. BidaskClub raised CryoPort from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, March 21st. Needham & Company LLC reaffirmed a “buy” rating and set a $11.00 price objective (up previously from $10.00) on shares of CryoPort in a research note on Thursday, March 8th. Finally, ValuEngine raised CryoPort from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. Five investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. CryoPort has an average rating of “Buy” and a consensus target price of $11.63.
In related news, CEO Jerrell Shelton sold 29,257 shares of the stock in a transaction on Tuesday, March 13th. The stock was sold at an average price of $9.83, for a total transaction of $287,596.31. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 9.60% of the stock is owned by company insiders.
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Creative Planning acquired a new stake in CryoPort in the 4th quarter worth about $5,176,000. Pier Capital LLC acquired a new stake in CryoPort in the 4th quarter worth about $2,916,000. Millennium Management LLC boosted its stake in CryoPort by 205.0% in the 1st quarter. Millennium Management LLC now owns 434,068 shares of the consumer goods maker’s stock worth $3,733,000 after buying an additional 291,737 shares during the last quarter. Allianz Asset Management GmbH boosted its stake in CryoPort by 240.5% in the 4th quarter. Allianz Asset Management GmbH now owns 387,099 shares of the consumer goods maker’s stock worth $3,325,000 after buying an additional 273,426 shares during the last quarter. Finally, BlackRock Inc. boosted its stake in CryoPort by 154.6% in the 1st quarter. BlackRock Inc. now owns 287,269 shares of the consumer goods maker’s stock worth $2,470,000 after buying an additional 174,440 shares during the last quarter. 24.48% of the stock is currently owned by institutional investors and hedge funds.
CYRX opened at $9.44 on Friday. The firm has a market cap of $259.74 million, a P/E ratio of -27.76 and a beta of 0.71. CryoPort has a 52 week low of $3.08 and a 52 week high of $10.40.
CryoPort Company Profile
Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.